This infosheet provides a simple explanation of chronic rheumatic and musculoskeletal disorders (RMDs) and highlights the importance of ensuring that people with such conditions are supported to remain in work or return to work through workplace accommodations — particularly as RMDs become more...

This checklist includes questions on working postures of the back and neck, arms and hands, legs during sitting and standing tasks. It also gives examples of the type of action at a technical, organisational and individual level that can be put in place to prevent or reduce the risks caused by...

This report presents eight case studies of people with chronic musculoskeletal disorders (MSDs) who successfully returned to work after sick leave or continued to work with the MSD. The studies aim to examine the experiences of these workers — who were recruited from a variety of organisations...

This publication summarises a report that presents eight case studies of people with chronic musculoskeletal disorders (MSDs) who successfully returned to work after sick leave or continued to work with the MSD. The studies aim to examine the experiences of these workers — who were recruited from a...

This fact sheet highlights the key findings of the EU-OSHA's prevention report, which focuses on the prevention of MSDs and the development and progress made in this area since the previous MSDs campaign in 2000. The report consists of two parts: a state-of-the-art review of the research literature...

This report focuses on the retention, reintegration and rehabilitation of workers with MSDs. It comes in two parts: a literature review on the effectiveness of work-related interventions, and an overview of policy initiatives in Europe and at the international level.

Musculoskeletal disorders (MSDs) are the most common workrelated problem in Europe. Almost 24 % of the EU-25 workers report suffering from backache and 22 % complain about muscular pains. Both conditions are more prevalent in the new Member States, 39 % and 36 % respectively.